谷歌浏览器插件
订阅小程序
在清言上使用

Phase I Study Evaluating Safety, Pharmacokinetics (PK), Pharmacodynamics, and Preliminary Efficacy of ABBV-428, First-in-class Mesothelin (MSLN)-CD40 Bispecific, in Patients (pts) with Advanced Solid Tumours

Annals of Oncology(2019)

引用 4|浏览84
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要